Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|September 1, 1985
Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placeboF J Cummings, R Gray, T E Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancerC L Loprinzi, D C Tormey, P Rasmussen, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancerF J Cummings, R Gray, T E Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinomaG Falkson, J M MacIntyre, A J Schutt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III studyH C Falkson, R Gray, W H Wolberg, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 22, 1986
Granulocytic sarcoma of the kidney in a patient with acute myelomonocytic leukaemia. A case reportB Klein, G Falkson, I W Simson, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.
Pageof 20